Authors
Latest:
Schizophrenia Costs for Newly Diagnosed Versus Previously Diagnosed PatientsPreviously diagnosed schizophrenia patients have lower inpatient and higher drug costs compared with newly diagnosed patients, possibly indicating better control of their disease.
Latest:
GoutGout is a chronic, inflammatory form of arthritis that is increasing in prevalence in the United States. There are a variety of pharmacologic and nonpharmacologic options for treating and preventing flares of gout.
Latest:
Enhancing the Strategy for Specialty PharmaceuticalsStrategies for controlling use of specialty pharmaceuticals should focus on situations where these agents are used inappropriately and on improvement of the complex billing process.
Latest:
Hormone Therapy Adherence and Costs in Women With Breast CancerSuboptimal adherence to hormone therapy was associated with higher medical costs, but optimal adherence was not associated with total cost savings across a 4-year period.
Latest:
Make the Most of the Conference ExperienceAs more pharmacy technicians join their rolls, organizations gear meeting content toward these key professionals.
Latest:
Self-Reported Plan Switching in Medicare Part D: 2006-2010Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.
Latest:
What Are the Challenges? Management of Patient CareOnline tools are shaping the ways in which utilization management is deployed.
Latest:
Best Practices in Transforming Chronic Pain CareThe number of opioids prescribed in the Untied States was approximately 3 times as high in 2015 as it was in 1999.
Latest:
How Can Pharmacists Help Patients Lower Medication Costs?There are numerous methods by which to obtain medications at a reduced cost, and pharmacists are perfectly positioned to help navigate this process
Latest:
The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late DevelopmentGiven the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.
Latest:
Cost-Effectiveness of Medication Therapy Management in Part D Diabetic EnrolleesPharmacist-delivered medication therapy management is a cost-effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk diabetic Medicare patients.
Latest:
Pharmacists' Role in the Management of Perioperative AnalgesiaMore than 75% of patients who undergo surgery experience moderate to severe acute postoperative pain that begins immediately following surgery and may extend beyond hospital discharge.
Latest:
Value-Based Care Requires Specialty Pharmacy Scale With Broad Capabilities to Deliver Enhanced Patient ServicesWithin the evolving value-based care environment, there is great opportunity for specialty pharmacies to help support this new payer transformation.
Latest:
mHealth Emerges as the New Essential Strategy for Specialty PharmaciesHealth care providers can utilize mobile health technology to provide patients with targeted adherence reminders and disease management guidance.
Latest:
Impact of Co-Payment Discounts on Antidepressant Medication Adherence and CostsA unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
Latest:
Did It Make a Sound? Becoming Leaders in an Era of Quality CareFor a positive impact to be made, the results of our research must be accessible to those who stand to benefit from it.
Latest:
Unlikely Allies: Community Collaborations Galvanize the Asheville ProjectDr. Heller is an assistant professor of pharmacy practice and administration at Lloyd L. Gregory School of Pharmacy, West Palm Beach, Fla.
Latest:
Kcentra by CSL BehringKcentra is the first nonactivated 4-factor prothrombin complex concentrate for the urgent reversal of acquired coagulation deficiency induced by vitamin K antagonist therapy.
Latest:
Navigating Paxlovid Interactions With AnticoagulantsInteractions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.
Latest:
Gaps in Immunization MeasurementIn the United States, vaccine-preventable diseases cause tens of thousands of deaths each year.
Latest:
The Community Pharmacist: Frontline Care Provider for VapingAs more vaping cases are reported, patients may desire answers from their trusted providers.
Latest:
Understanding the Veterinary PatientCurrently pharmacists and pharmacy technicians have little to no formal education regarding our veterinary patients, although our responsibility to them is the same as our human patients.
Latest:
Specialty Oncology Pharmacy PracticesA SORx CCS Program is the touchstone for all other SORx operations, and for clients, it is the face of the pharmacy. An efficient, personalized CCS staffed by highly motivated, registered pharmacy technicians results in very satisfied clients.
Latest:
Community Pharmacist Services: The Missing Link to Optimizing Medication AdherenceFailure to follow through on prescribed drug regimens is a common—and costly—problem: Of the 32 million adult Americans who take 3 or more medications daily, 75% are nonadherent.
Latest:
Prevention is Key for Non-Small Cell Lung CancerDespite numerous treatment advances, early detection, public education, and smoking cessation are the best bets.
